Liver transplant assessment for hepatocellular carcinoma: a single-centre experience.

ABSTRACT:

Objective

The incidence of hepatocellular carcinoma (HCC) continues to rise dramatically in the UK. Liver transplantation offers a potential cure and there is a large body of evidence demonstrating good outcomes. However, there is a paucity of data on the assessment, acceptance rates, and reasons for turning down liver transplantation in HCC.

Methods

We undertook an analysis of all patients with HCC referred for liver transplant assessment to a tertiary liver centre between January 2015 and January 2020. Patient and tumour demographics, assessment outcomes and overall survival were analysed. Multivariate analysis was performed on factors affecting listing decisions. To evaluate the impact of the COVID-19 pandemic, data collection was extended from March 2020 to March 2021.

SUBMITTER: Faulkes RE 

PROVIDER: S-EPMC12418541 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature